CHD4 Orchestrates Chromatin Remodeling to Activate the c‐Myc Signaling Pathway in Cancer Pathogenesis
ABSTRACT Chromatin abnormalities are a hallmark of cancer, but the role of the chromatin remodeler CHD4 in multiple myeloma (MM) remains unclear. This study aims to elucidate how CHD4 drives MM progression and to explore targeted therapeutic strategies. Using CHD4 overexpression and knockdown models...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley
2026-06-01
|
| Collection: | MedComm – Oncology |
| Sujets: | |
| Accès en ligne: | https://doi.org/10.1002/mog2.70073 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
